Records containing: Virus Diseases
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-08-24A Phase I, First-Time-in Human (FTiH), Open-label, Dose Escalation, Non-randomized Study to Assess Safety, Reactogenicity and Immune Response of a CoV-2 SAM (LNP) Vaccine When Administered Intramuscularly on a 0, 1 Month Schedule in Healthy Adults 18 to 50 Years of Age
-
CLINICAL_TRIALS study record update · 2026-04-14A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
-
CLINICAL_TRIALS study record update · 2026-03-12Effect of Xuanfei Jiangzhuo Decoction on Clinical Remission in Influenza-Induced AECOPD: Study Protocol for a Prospective, Real-World Cohort Study
-
CLINICAL_TRIALS study record update · 2026-03-03Hypertonic Saline Nasal Irrigation and Gargling for Suspected or Confirmed COVID-19: Pragmatic Web-based Bayesian Adaptive Randomised Controlled Trial (ELVIS COVID-19)
-
CLINICAL_TRIALS study record update · 2025-12-31Quality of Life After Primary Transoral Robotic Surgery vs Intensity-modulated Radiotherapy for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma: A Randomized National Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-24Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes
-
CLINICAL_TRIALS study record update · 2025-10-16Evaluating the Durability of the Human Immune Response to the JYNNEOS Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine
-
CLINICAL_TRIALS study record update · 2025-09-30A Trial in Participants With Chronic Obstructive Pulmonary Disease (COPD) to Evaluate the Impact of Vapendavir on the Development of Lower Respiratory Tract Symptoms Following Rhinovirus Challenge
-
CLINICAL_TRIALS study record update · 2025-07-08Analysis of Single Respiratory Viral Infections Versus Co-infections in the Post-pandemic Era: Prevalence and ICU Needs in Hospitalized Adults
-
CLINICAL_TRIALS study record update · 2025-05-11A Phase 2, Open-label, Study to Evaluate the Safety and Immunogenicity of a Heterologous 2-dose Vaccination Regimen Using Ad26.ZEBOV, MVA-BN-Filo in Adults and Children Originally Enrolled in the Control Arm of the EBOVAC-Salone Study
-
CLINICAL_TRIALS study record update · 2025-04-29Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men
-
CLINICAL_TRIALS study record update · 2025-01-22A Phase 1, Randomized, Observer-Blind, Multi-Center, Dose Ranging Study to Evaluate the Immunogenicity, Safety and Tolerability of Different Formulations of an Adjuvanted or Non-Adjuvanted Cell Culture-derived A/H2N3 Subunit Influenza Virus Vaccine in Healthy Subjects 18 Years and Above
-
CLINICAL_TRIALS study record update · 2025-01-14Safety and Efficacy of ALLOSTIM® Universal Anti-Viral Immunodulatory Vaccine for Healthy Elderly Adults
-
CLINICAL_TRIALS study record update · 2024-12-13A Phase 2, Multi-Center, Randomized, Observer-Blind Study, to Evaluate Safety and Immunogenicity of Homologous or Heterologous Priming and Booster Vaccinations With H5N8 or H5N6 MF59-adjuvanted, Cell Culture-derived Influenza Vaccine in Healthy Subjects ≥18 Years of Age
-
CLINICAL_TRIALS study record update · 2024-12-12LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System
-
CLINICAL_TRIALS study record update · 2024-09-25Post-COVID-19 Monitoring in Routine Health Insurance Data
-
CLINICAL_TRIALS study record update · 2024-07-18A Phase 3, Open-label, Multicenter Study to Evaluate Long-term Immunogenicity and Boostability of Immune Responses in Adults Who Received Different Primary Vaccination Regimens of Pre-exposure Prophylaxis With Purified Chick-Embryo Cell Rabies Vaccine Administered Concomitantly or Separately From a Japanese Encephalitis Vaccine.
-
CLINICAL_TRIALS study record update · 2024-07-12A Multi-site, Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of Four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-19 Using Different Dosing Regimens in Healthy and Immunocompromised Adults
-
CLINICAL_TRIALS study record update · 2024-07-05Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease: Prospective, Controlled Medical Device Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-05-31Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19
-
CLINICAL_TRIALS study record update · 2024-03-28Long Term Immunogenicity up to 15 Years After the First Booster Immunization With GSK Biologicals' Encepur Adults (Polygeline-free Tick-Borne Encephalitis Vaccine for Adults) in Adults Who Received 1 of 3 Different Primary Vaccination Schedules
-
CLINICAL_TRIALS study record update · 2024-03-06The Association Between Tobacco Use and COVID-19 Infection and Adverse Outcomes in Three Nordic Countries: a Pooled Analysis
-
CLINICAL_TRIALS study record update · 2024-03-01Safety and Immunogenicity of GSK's Rabies G SAM (CNE) Vaccine [GSK3903133A] in Healthy Adults.
-
CLINICAL_TRIALS study record update · 2024-01-18A Phase I, First-Time-in Human (FTiH), Open-label, Dose Escalation, Non-randomized Study to Assess Safety, Reactogenicity and Immune Response of a CoV-2 SAM (LNP) Vaccine When Administered Intramuscularly on a 0, 1 Month Schedule in Healthy Adults 18 to 50 Years of Age
-
CLINICAL_TRIALS study record update · 2023-12-15Clinic-based ART Diagnostic Evaluation